|
|
|
|
|
|
|
|
|
|
|
NDO Surgical (Acquired) |
|
|
|
Achaogen is discovering and developing life-saving antibiotics. |
Synosia Therapeutics is a CNS focused company developing novel treatments for psychiatric and neurological disorders. |
  |
Euro Ventures, Inc. is an incubator company forming development stage start ups through acquisition of assets from European-based pharma companies. |
Sebacia is developing novel technology to address a large unmet need in dermatology. |
Semprae Laboratories, Inc. is a company founded by women and focused on women's sexuality. |
  |
Sentient is a seed stage start up company focused on developing products for outpatient interventional procedures. |
  |
Seredigm is focused on developing novel drugs that protect against tissue damage in a variety of acute or chronic medical conditions. |
Spark Diagnostics is a diagnostics company utilizing next-gen sequencing technology to more efficiently and effectively diagnose disease. |
(NASDAQ:CADX) |
Kythera is focused on science and innovation in aesthetic dermatology. |
(NASDAQ:ALXA) |
Amira is an R&D Company focused on the development of novel therapies for respiratory and other inflammatory diseases. |
Amphora will create the first comprehensive chemical genomics knowledge set, detailing the interactions of small drug molecules with a broad array of protein targets. The company plans to commercialize this knowledge set in a series of drug discovery alliances with pharmaceutical and biotech companies and to sell drug candidates that Amphora has internally developed. |
Antipodean is a drug development company focused on a platform of mitochondria targeted antioxidants for several degenerative diseases. |
Delivery of simple, accessible bio-molecule detection and analysis solutions to the life sciences market. |
5AM Ventures is a seed-stage fund focused on creating and building biotech companies. |
FivePrime accelerates drug discovery by rapidly isolating and assaying the world's largest collection of pharmaceutically relevant targets and therapeutics from the human genome. |
(FLDM in registration) |
(NASDAQ:GHDX) |
(NASDAQ:HLCS) |
ISB Accelerator Corporation is building the next generation of life-enhancing biotechnology companies by providing world-class scientific and technical expertise, committed venture capital funding, state-of-the-art facilities and experienced biotechnology business management to accelerate the development of nascent leading-edge biotechnologies. |
![]() |
![]() |
Natural language processing technology and services for medical coding and data analysis. |
(NASDAQ:JAZZ) |
|
Metabolex is an R&D based company focused on novel therapies for the treatment of diabetes and related metabolic disorders. |
![]() |
Groove BioPharma develops therapeutics using Minor Groove Binder Technology (MGB) to affect cellular processes involving microRNAs. |
|
![]() |
(NASDAQ:TSPT) |
(Sold to Merck) |
(Sold to Affymetrix) |
(PHRM : Sold to Celgene) |
Phenomix is a biopharmaceutical company focused on dicovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. |
Pathwork Diagnostics is developing innovative molecular diagnostic tests for cancer. |
APT Pharmaceuticals is developing inhaled therapies for severe lung disorders. |
Okairos is using a best-in-class, proprietary genetic vaccine technology to develop vaccines for major unmet diseases, such as malaria, hepatitis C (HCV) and a universal influenza vaccine. |
OpGen is developing a molecular biology system to automate rapid (2-hour) identification of infection-causing bacteria for deployment in the central microbiology lab. |
(NASDAQ:TSRX) |
Vital Therapies has developed the first human cell artificial liver, trade-named ELAD (Extracoporeal Liver Assist Device). |
(Australian Stock Exchange:IPD) |
| San Francisco, CA |
|
(Sold to GlaxoSmithKline) |
Saegis Pharmaceuticals is dedicated to developing new medicines that protect and improve memory and cognition. |
(Sold to Cephalon) |
(Sold to Takeda) |
CardioNow provides image management services for cardiology departments. |
Cogent provides comprehensive hospitalist programs for acute care hospitals. |
Collabrys provides outsourced, software-driven, full-service solutions that enable marketing professionals to launch new products, build brands, and increase consumer share. |
(Acquired by Merge Healthcare) |
| Minneapolis, MN |
RedBrick Health provides employers with an innovative technology and financing platform for achieving high levels of employee health engagement and reducing avoidable healthcare costs. |
MedManage develops and deploys technology-based drug sampling solutions for pharmaceutical companies to accelerate prescription drug sales. |
New Hope Bariatrics develops, markets, and operates centers of excellence for obesity surgery, providing outpatient surgery and related pre and post surgical care. |
Skylight develops and operates hospital room interactive communication systems to provide hospital administrative and patient services. |
Titan develops and operates ambulatory surgicenters. |
Vantage develops and operates state-of-the-art radiation oncology centers. |
(Acquired by Johnson & Johnson) |
AcuFocus is developing a corneal implant to treat presbyopia (the need for reading glasses). |
Calypso Medical Technologies is a Seattle-based, early-stage medical device company developing a novel method of localizing tumors to better guide radiation therapy. |
Cameron Health is developing a novel Implantable Cardioverting Defibrillator (S-ICD) without intravenous leads. |
|
Cellutions is developing minimally invasive devices for cosmetic procedures. |
Glaukos is developing an implantable device to treat glaucoma. |
GluMetrics, Inc. is a medical device company focused on bringing life-saving glucose monitoring products to the healthcare market. |
Inogen develops and manufactures highly innovative, portable, lightweight oxygen concentrators for the home and ambulatory oxygen markets. |
(NASDAQ:PODD) |
(NASDAQ:ILSE) |
|
(Sold to Medicis) |
|
MitraLife is developing a medical device for the treatment of congestive heart failure. Acquired by ev3. |
NDO Surgical develops, manufactures, and markets innovative endoscopic technologies for gastrointestinal disease. |
(Acquired by Intuitive Surgical) |
NeoVista is developing radiation delivery technology to treat age-related macular degeneration (AMD) |
Neurotech Pharmaceuticals is pioneering encapsulated cell technology as a drug delivery platform for retinal degenerative diseases. |
![]() |
Nexis Vision is evaluating a variety of technologies to address important unmet patient needs in key ophthalmic markets. |
Refractec develops and markets new products using radiofrequency technology for the treatment of farsightedness and presbyopia. |
Intuity Medical is developing products that will enhance glucose monitoring for diabetic patients. |
![]() |
Novel device for treating lung diseases |
Rox is developing devices for treatment of diseases of the respiratory system. |
Fidelis Senor Care develops and operates specialized health plans for frail seniors. |
Second Sight is developing a prosthetic retinal implant which will return functional vision to patients blinded from retinitis pigmentosa and age-related macular degeneration. |
![]() |
Sequent Medical is developing novel devices for the treatment of vascular disease. |
Spiration is developing implantable surgical devices for the treatment of lung disease. |
St. Francis Medical offers a surgical implant for the treatment of spinal stenosis, a common cause of back pain, particularly in older patients. |
![]() |
![]() |
With a focus on inflammatory diseases, Flexion in-licenses clinically enabled drug candidates with high-value specialty potential and develops these to proof of concept (PoC) and beyond. |
Tensys is developing non-invasive blood pressure monitors and disposable sensors. |
(Acquired by Medtronic) |
Fovioptics is developing a novel non-invasive glucose monitoring technology. |
Celula is developing molecular diagnostics using advanced microfluidics technologies. |
![]() |
Ceterix is developing a new orthopedic suturing technology that is focused on improving ease-of-use and operative speed. |
![]() |
Transcend Medical is an opthalmic technology incubator. |
  |
ForSight New Co II is developing an implantable drug delivery device. |
![]() |
ForSight VISION4 is evaluating a variety of technologies to address important unmet patient needs in key ophthalmic markets. |
![]() |
ForSight Vision 5, Inc. is developing novel ocular drug delivery technologies. |
![]() |
  |
Portaero, Inc. is developing a treatment for emphysema. |
|
Benvenue is developing innovative spine-related technology. |
![]() |
![]() |
NovaLign is developing a therapeutic device for long bone fracture fixation. |
![]() |
WaveTec Vision is developing ORange™, a novel wavefront measurement technology that provides on-demand, intraoperative information to the refractive cataract surgeon. |
VLST Corp. has developed a novel and streamlined approach to speed the development of effective therapeutics for the treatment of inflammatory and autoimmune diseases. |
|
Homestead Clinical Corporation commercializes technologies that have broad utility in the development of novel diagnostic, prognostic, and theranostic tools. |
![]() |
![]() |
Theraclone Sciences, Inc. is focused on developing novel human therapeutic antibodies for the treatment of infectious diseases. |
Ambrx Inc. is a company working on a protein technology platform with a focus on protein engineering. |
|
VerCo is a seed stage company focused on sourcing and offshore development of clinical stage oncology products. |
(Sold to Bausch & Lomb) |
Leading industry provider of innovative 3-D technology solutions facilitating and improving the quality of orthodontic care. |
![]() |
![]() |
|
Anza Therapeutics is developing therapeutic vaccines for infectious disease and cancer. |
![]() |
![]() |
Advanced ICU care provides remote (telemedicine) patient care services, known as "virtual ICUs", for community hospital intensive care units (ICUs). The virtual ICU is a cost-efficient model for improving care and reducing mortality. |
![]() |
![]() |
Anaphore is a protein therapeutics company which is developing improved biologic therapeutics using proprietary established platforms. |
![]() |
![]() |
Immune Design Corp. is a biotechnology company focused on developing a broad platform of novel vaccines (both therapeutic and prophylactic) for the treatment of infectious disease. |
Inception Sciences is a drug discovery incubator based on a proven team of drug developers. The company is translating biological insights into novel, first-in-class small molecule drugs for modifying diseases of aging. |
![]() |
![]() |
LenSx Lasers is developing a next generation laser to improve cataract surgery safety and efficacy. |
![]() |
![]() |
|
Rennovia is an early stage chemical development company working to produce specialty chemicals from renewable feedstock. |
Kinestral Technologies is developing novel new chemistry applied to building materials for energy efficiency. |
![]() |
![]() |
Novasys Medical is developing innovative therapies in women's health, and has recently launched its first product: the Renessa® System, a proprietary, non-surgical treatment for female stress urinary incontinence (SUI). |
![]() |
![]() |
PhaseRx is developing a novel approach to intracellular delivery of macromolecules. |
![]() |
![]() |
Respicardia, Inc. is developing an implantable medical device targeted at improving the outcomes of Congestive Heart Failure (CHF) by treating Central Sleep Apnea. |
![]() |
![]() |
Lutonix, Inc. is developing drug coated balloon angioplasty technology for the treatment and prevention of coronary and peripheral artery stenosis caused by atherosclerosis. |
![]() |
![]() |
Microfabrica, Inc is a leading developer of micro and millimeter-scale devices and micro machines used in a wide variety of micro-invasive medical device applications, as well as in applications in the electronics and defense industries. |
![]() |
Minerva is developing a medical device for treating excessive menstrual bleeding. |
![]() |
![]() |
Alter-G is marketing its "G-Trainer" technology, a treadmill system that reduces the users' body weight/impact of running and thereby enhances physical rehabilitation from orthopedic or neurological injury. |
![]() |
![]() |
Veracyte is a start-up company focused on molecular diagnostics. |
![]() |
|
AestheTec is developing autologous fat technologies for aesthetic and reconstructive markets. |
![]() |
|
ATI is developing an implantable neuromodulation system for patients suffering from migraines and other severe headaches. |
![]() |
![]() |
|
Clovis Oncology is a newly formed company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. |
![]() |
Intersection Medical is developing a cardiovascular monitoring system for patients with congestive heart failure. |
![]() |
![]() |
Ocular Therapeutix has a novel PEG hydrogel platform technology focused on ocular sealant, wound closure, and drug delivery. |
![]() ![]() |
||
|
|
|
|
|
|
||
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
|
|
||||||||||||||||
|
|